Australian (ASX) Stock Market Forum

ME1 - Melodiol Global Health

Jump to new
System

System

Joined
27 June 2010
Posts
4,147
Reactions
309
Creso Pharma are in the business of developing, registering and commercialising pharmaceutical-grade cannabis and hemp-based products for use across a broad spectrum of consumer, industry and research applications.

It is anticipated that CPH will list on the ASX during October 2016.

http://cresopharma.com
 
Another one.

Marijuana is touted as being safer and more effective than opiates. The opiate market word wide is HUGE, especially in the USA.

Parker Lewis.

I wouldn't touch MMJ with a barge pole, due to its early associations.
 
Gringotts Bank said:
Another one.

Marijuana is touted as being safer and more effective than opiates. The opiate market word wide is HUGE, especially in the USA.

Parker Lewis.

I wouldn't touch MMJ with a barge pole, due to its early associations.
Click to expand...

For a 20c IPO, they came out smokin' ;)

CPH i01 20-10-16.png

Most likely scalpers that dominate the first day, so I haven't been buying yet.
It will be interesting though, and possibly quite rewarding, to keep this on the watch list.
 
pixel said:
For a 20c IPO, they came out smokin' ;)

View attachment 68494

Most likely scalpers that dominate the first day, so I haven't been buying yet.
It will be interesting though, and possibly quite rewarding, to keep this on the watch list.
Click to expand...

Nothing rewarding about keeping a stock on your watch list mate! It will be above 30c tomorrow!
 
News release
Creso just received first delivery consignment from Canada,checkout their website.
 
more news:
Creso Pharma to launch innovative hemp‐based animal health products with
Virbac in Switzerland

CPH pm 07-08-17.png


Nonna may have had an early taste :)
nonna.jpg
 
7 years later -
CPH Creso Pharma has expanded into China's $39.6 billion health food market by signing a deal with a local hemp producer, and is hinting at even more opportunities to expand.

The Australian medical cannabis company on Monday said it signed a commercial partnership with China's Zhejiang Kingdom Creative, which will purchase and import its animal and human health hemp- and cannabis-derived products into the local market.

Kingdom Creative, which is primarily a hemp- and flax-based linen production company, will also build a health food, nutraceuticals, body care and cosmetic company, allowing Creso further access and scale in China.

upload_2017-11-20_20-20-6.png



The medicinal cannabis company has opened four offices across China to build a sales and marketing presence and further local distribution options in China for its products.

'It will also enable Creso to rapidly expand into other Asian markets,' the company said in a statement.

The Chinese health food market - Chinese medicine - is currently valued at $39.6 billion and is projected to grow by 10 per cent every year between now and 2025.



Creso said sales for medical cannabis in China are expected to grow with the country progressively opening up legislation to allow hemp-based and medical cannabis products to be available to patients.
 
Time for an update after 17 months of no activity in this thread, CPH has recently signed an agreement with a business i found a couple of days ago, CDA - Cannabis Doctors Australia.
CDA will retail some of CPH's products at its clinic in Burliegh Heads (Qld) and distribute to other health providers, CDA is about to launch a crowd funding campaign to raise 2 million.

https://clients3.weblink.com.au/pdf/CPH/02100434.pdf

I have decided to participate in the CDA crowd funding opportunity as i think the distribution and retailing of cannabis in Australia is a better business than product development under the
current legal restraints in Australia ~ the CPH share price hasn't done to well since the POT stocks euphoria of late 17 early 18, there is some potential for a distributor/retailer to become
dominant if they can get early success as CDA has already done..

https://www.cdaclinics.com.au/investors/
~
CPHall.jpg
 
Creso Pharma is to be acquired by Canadian listed PharmaCielo Ltd (TSXV: PCLO) for AUD$122 million at AUD $0.63per share. PharmaCielo is a leading cannabis company listed on Canada's TSX Venture Exchange with a current market capitalisation of approximately CAD$675 million.

The Creso Pharma Board of Directors have unanimously recommended that shareholders and listed option holders vote in favour of the Share Scheme and the Option Scheme respectively, in the absence of a superior proposal and subject to an Independent Expert opining that the Schemes are in the best interests of Creso Pharma security holders.

Yesterday's closing price for CPH was 42c, so 63c per share represents a decent premium over the market price. The take over announcement has seen it surge 33.33% to 56c this morning.
 
This is a complete basket case of a company, but with the price just falling down though 10c today after fairly recently having a 63c takeover offer (which didn't go through) and plenty of holders still strangely believing in it, there's a chance of a brief spike in price coming up so I tipped it in the March competition. Wouldn't put my own money within 20 miles of it though.
 

Similar threads

System
LGP - Little Green Pharma
2
Replies
24
Views
5K
noirua
noirua
Top